- Home
- BFRI vs KAVL Comparison
BFRI vs KAVL Comparison
Compare BFRI & KAVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BFRI
- KAVL
- Stock Information
- Founded
- BFRI 1997
- KAVL 1998
- Country
- BFRI United States
- KAVL United States
- Employees
- BFRI N/A
- KAVL N/A
- Industry
- BFRI Biotechnology: Pharmaceutical Preparations
- KAVL Medicinal Chemicals and Botanical Products
- Sector
- BFRI Health Care
- KAVL Health Care
- Exchange
- BFRI Nasdaq
- KAVL Nasdaq
- Market Cap
- BFRI 6.2M
- KAVL 6.2M
- IPO Year
- BFRI 2021
- KAVL N/A
- Fundamental
- Price
- BFRI $0.76
- KAVL $0.80
- Analyst Decision
- BFRI Strong Buy
- KAVL
- Analyst Count
- BFRI 1
- KAVL 0
- Target Price
- BFRI $7.00
- KAVL N/A
- AVG Volume (30 Days)
- BFRI 7.3M
- KAVL 176.2K
- Earning Date
- BFRI 11-13-2024
- KAVL 11-29-2024
- Dividend Yield
- BFRI N/A
- KAVL N/A
- EPS Growth
- BFRI N/A
- KAVL N/A
- EPS
- BFRI N/A
- KAVL N/A
- Revenue
- BFRI $35,358,000.00
- KAVL $10,108,906.00
- Revenue This Year
- BFRI $19.11
- KAVL $652.90
- Revenue Next Year
- BFRI $20.16
- KAVL N/A
- P/E Ratio
- BFRI N/A
- KAVL N/A
- Revenue Growth
- BFRI 5.17
- KAVL N/A
- 52 Week Low
- BFRI $0.61
- KAVL $0.58
- 52 Week High
- BFRI $4.04
- KAVL $9.69
- Technical
- Relative Strength Index (RSI)
- BFRI 43.25
- KAVL 37.95
- Support Level
- BFRI $0.65
- KAVL $0.85
- Resistance Level
- BFRI $0.79
- KAVL $0.98
- Average True Range (ATR)
- BFRI 0.11
- KAVL 0.07
- MACD
- BFRI -0.01
- KAVL -0.02
- Stochastic Oscillator
- BFRI 26.41
- KAVL 5.12
About BFRI Biofrontera Inc.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy (PDT) and topical antibiotics. Its licensed products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. Its licensed product is Ameluz, which is a prescription drug approved for use in combination with the RhodoLED lamp series, for PDT (when used together, Ameluz PDT). including the complementary product BF-RhodoLED, and Xepi.
About KAVL Kaival Brands Innovations Group Inc.
Kaival Brands Innovations Group Inc is focused on growing and incubating innovative and profitable products. The company is engaged in the sale, marketing and distribution of electronic nicotine delivery system (ENDS) products and related components. Its primary product includes Bidi Stick. The BIDI Stick comes in a variety of flavor options for adult cigarette smokers.